By: The 340Best Team | July 7, 2021
As drug manufacturers request more oversight and scrutiny surrounding the 340B program intensifies, compliance with regulations must be your top priority when participating in the 340B program. Recently, 340B eligible covered entities utilizing contract pharmacies have become a primary target for drug manufacturers and Pharmacy Benefit Managers (PBM’s) seeking to stifle the overall program under the guise of preventing duplicate discounts. As such, now is a good time to evaluate the health of your contract pharmacy program.
Click here to read on!